Amalgamated Bank Prometheus Biosciences, Inc. Transaction History

Amalgamated Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$103.46 - $126.29 $83,802 - $102,294	-810 Reduced 14.14%	4,917 $528,000
Q4 2022 Feb 10, 2023	BUY	$36.06 - $117.21 $27,946 - $90,837	775 Added 15.65%	5,727 $630,000
Q3 2022 Nov 09, 2022	BUY	$28.17 - $59.01 $8,394 - $17,584	298 Added 6.4%	4,952 $292,000
Q2 2022 Aug 15, 2022	BUY	$22.39 - $38.94 $19,524 - $33,955	872 Added 23.06%	4,654 $131,000
Q1 2022 Jun 30, 2022	BUY	$30.13 - $50.0 $113,951 - $189,100	3,782 New	3,782 $143,000

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.